Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues Y Dumont, JC Martel, A Fournier, S St-Pierre, R Quirion Progress in neurobiology 38 (2), 125-167, 1992 | 492 | 1992 |
Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia JC Martel, S Gatti McArthur Frontiers in pharmacology 11, 1003, 2020 | 215 | 2020 |
Neuropeptide Y receptors in rat brain: autoradiographic localization JC Martel, S St-Pierre, R Quirion Peptides 7 (1), 55-60, 1986 | 194 | 1986 |
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys. PJ Blanchet, F Calon, JC Martel, PJ Bédard, T Di Paolo, RR Walters, ... Journal of Pharmacology and Experimental Therapeutics 272 (2), 854-859, 1995 | 186 | 1995 |
Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist A Newman‐Tancredi, JC Martel, MB Assié, J Buritova, E Lauressergues, ... British journal of pharmacology 156 (2), 338-353, 2009 | 153 | 2009 |
Neuropeptide Y: localization in the central nervous system and neuroendocrine functions JM Danger, MC Tonon, BG Jenks, S Saint‐Pierre, JC Martel, A Fasolo, ... Fundamental & clinical pharmacology 4 (3), 307-340, 1990 | 149 | 1990 |
The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart F Rioux, H Bachelard, JC Martel, S St-Pierre Peptides 7 (1), 27-31, 1986 | 148 | 1986 |
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex F Calon, M Goulet, PJ Blanchet, JC Martel, MF Piercey, PJ Be, T Di Paolo Brain research 680 (1-2), 43-52, 1995 | 130 | 1995 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety AL Auclair, JC Martel, MB Assié, L Bardin, P Heusler, D Cussac, M Marien, ... Neuropharmacology 70, 338-347, 2013 | 129 | 2013 |
Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type R Quirion, JC Martel, Y Robitaille, P Etienne, P Wood, NPV Nair, ... Canadian Journal of Neurological Sciences 13 (S4), 503-510, 1986 | 119 | 1986 |
Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells D Cussac, E Boutet-Robinet, MC Ailhaud, A Newman-Tancredi, JC Martel, ... European journal of pharmacology 594 (1-3), 32-38, 2008 | 106 | 2008 |
Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus T Debeir, L Ginestet, C François, S Laurens, JC Martel, P Chopin, ... Experimental neurology 193 (2), 444-454, 2005 | 97 | 2005 |
Neuropeptide Y in the intermediate lobe of the frog pituitary acts as an α-MSH-release inhibiting factor JM Danger, F Leboulenger, J Guy, MC Tonon, M Benyamina, JC Martel, ... Life sciences 39 (13), 1183-1192, 1986 | 97 | 1986 |
Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease JC Martel, R Alagar, Y Robitaille, R Quirion Brain research 519 (1-2), 228-235, 1990 | 74 | 1990 |
Effects of the α2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death S Bauer, E Moyse, F Jourdan, F Colpaert, JC Martel, M Marien Neuroscience 117 (2), 281-291, 2003 | 71 | 2003 |
Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra R Quirion, P Gaudreau, JC Martel, S St-Pierre, N Zamir Brain research 331 (2), 358-362, 1985 | 69 | 1985 |
Quantitative autoradiographic distribution of [125I] Bolton-Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with [125I] peptide YY receptor sites JC Martel, A Fournier, S St Pierre, R Quirion Neuroscience 36 (1), 255-283, 1990 | 64 | 1990 |
Structural study of the N-terminal segment of neuropeptide tyrosine M Forest, JC Martel, S St-Pierre, R Quirion, A Fournier Journal of medicinal chemistry 33 (6), 1615-1619, 1990 | 56 | 1990 |
Comparison of [125I] Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species JC Martel, S St-Pierre, PJ Bédard, R Quirion Brain research 419 (1-2), 403-407, 1987 | 53 | 1987 |
WAY-100635 has high selectivity for serotonin 5-HT1A versus dopamine D4 receptors JC Martel, N Leduc, AM Ormière, V Faucillon, N Danty, C Culie, D Cussac, ... European Journal of Pharmacology 574 (1), 15-19, 2007 | 52 | 2007 |